A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients
A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients
The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.
Inclusion Criteria:
Exclusion Criteria:
Ciudad de Bs As, Argentina
Cote Du Palais, Quebec G1R 2J6, Canada
Carnaxide-lisboa, 2795-563, Portugal
La Coruã'a, 15006, Spain
La Laguna / Santa Cruz de Tenerife, 38320, Spain